The Scientist »

“The reason I think this line of research is particularly exciting is that it could very well get at an actual beginning of the disease, so that we could design therapeutics to perturb the colonization of bacteria… to see whether you can prevent a percentage of disease prevalence by getting rid of colonization. And that would totally change the types of therapies that a rheumatologist could use.”